首页> 外文期刊>JMIR pediatrics and parenting. >Clinical Characteristics of Children With COVID-19 in the United Arab Emirates: Cross-sectional Multicenter Study
【24h】

Clinical Characteristics of Children With COVID-19 in the United Arab Emirates: Cross-sectional Multicenter Study

机译:阿拉伯联合酋长国Covid-19儿童临床特征:横截面多中心研究

获取原文
       

摘要

Background COVID-19 has infected over 123 million people globally. The first confirmed case in the United Arab Emirates (UAE)?was reported on January 29, 2020. According to studies conducted in the early epicenters of the pandemic, COVID-19 has fared mildly in the pediatric population. To date, there is a lack of published data about COVID-19 infection among children in the Arabian region. Objective This study aims to investigate the clinical characteristics, laboratory findings, treatment, and outcomes of children with COVID-19. Methods This cross-sectional, multicenter study included children with confirmed COVID-19 infection admitted to 3 large hospitals in Dubai, UAE, between March 1 and June 15, 2020. Serial COVID-19 polymerase chain reaction (PCR) testing data were collected, and patients’ demographics, premorbid clinical characteristics, and inpatient hospital courses were examined. Results In all, 111 children were included in our study and represented 22 nationalities. Of these, 59 (53.2%) were boys. The mean age of the participants was 7 (SD 5.3) years. About 15.3% of children were younger than 1 year. Only 4 (3.6%) of them had pre-existing asthma, all of whom had uneventful courses. At presentation, of the 111 children, 43 (38.7%) were asymptomatic, 68 (61.2%) had mild or moderate symptoms, and none (0%) had severe illness requiring intensive care. Fever (23/111, 20.7%), cough (22/111, 19.8%), and rhinorrhea (17/111, 15.3%) were the most common presenting symptoms, and most reported symptoms resolved by day 5 of hospitalization. Most patients had no abnormality on chest x-ray. The most common laboratory abnormalities on admission included variations in neutrophil count (22/111, 24.7%), aspartate transaminase (18/111, 22.5%), alkaline phosphatase (29/111, 36.7%), and lactate dehydrogenase (31/111, 42.5%). Children were infrequently prescribed targeted medications, with only 4 (3.6%) receiving antibiotics. None of the 52 patients tested for viral coinfections were positive. COVID-19 PCR testing turned negative at a median of 10 days (IQR: 6-14) after the first positive test. Overall, there was no significant difference of time to negative PCR results between symptomatic and asymptomatic children. Conclusions This study of COVID-19 presentations and characteristics presents a first look into the burden of COVID-19 infection in the pediatric population in the UAE. We conclude that a large percentage of children experienced no symptoms and that severe COVID-19 disease is uncommon in the UAE. Various laboratory abnormalities were observed despite clinical stability. Ongoing surveillance, contact tracing, and public health measures will be important to contain future outbreaks.
机译:背景Covid-19在全球中感染了超过1.23亿人。阿拉伯联合酋长国(阿联酋)的第一个确认案例?于2020年1月29日举报。根据大流行早期震中的研究,Covid-19在儿科人口中有轻微。迄今为止,在阿拉伯地区的儿童中缺乏有关Covid-19感染的公布数据。目的本研究旨在探讨Covid-19儿童的临床特征,实验室发现,治疗和结果。方法使用这种横断面的多中心研究包括在3月1日至6月15日至6月15日期间在3月1日至6月15日期间在迪拜迪拜达到3大型医院的儿童。检查了患者的人口统计,预血压临床特征和住院医院课程。结果,我们的研究中包含111名儿童,并占22个民族。其中,59(53.2%)是男孩。参与者的平均年龄是7(SD 5.3)年。大约15.3%的儿童年轻于1年。他们中只有4(3.6%)已经存在预先存在的哮喘,所有这些课程都有不行的课程。在介绍中,111名儿童,43名(38.7%)是无症状的,68例(61.2%)有轻度或中度症状,无(0%)的严重疾病需要重症监护。发烧(23/111,20.7%),咳嗽(22/111,19.8%),rhinorrhea(17/111,15.3%)是最常见的呈现症状,最多报道的症状在附加期第5天得到解决。大多数患者在胸部X射线上没有异常。入学的最常见的实验室异常包括中性粒细胞计数(22 / 111,24.7%),天冬氨酸转氨酶(18 / 111,22.5%),碱性磷酸酶(29/111,36.7%)和乳酸脱氢酶(31/111 ,42.5%)。孩子们常常规定的靶向药物,只有4(3.6%)接受抗生素。 52名用于病毒辛纤维的52名患者均为阳性。 Covid-19 PCR测试在第一次阳性测试后在10天(IQR:6-14)中的中位数变为阴性。总体而言,对症状和无症状的儿童之间的阴性PCR没有显着的时间差异。结论本研究了Covid-19介绍和特征的研究表明,首先调查阿联酋儿科人群的Covid-19感染负担。我们得出结论,大量的儿童没有症状,而且严重的Covid-19疾病在阿联酋罕见。尽管临床稳定性,观察到各种实验室异常。持续监测,联系跟踪和公共卫生措施将重要遏制未来爆发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号